Incidence of Skin Changes in Patients with Myasthenia Gravis Prescribed Mycophenolate mofetil or Azathioprine (P1-1.Virtual)

Mycophenolate
DOI: 10.1212/wnl.98.18_supplement.271 Publication Date: 2023-12-06T21:32:24Z
ABSTRACT
To examine the impact of mycophenolate mofetil (MMF) and azathioprine (AZA) on incidence development skin lesions in patients with myasthenia gravis (MG).
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (0)
CITATIONS (0)